NANOPARTICLES & MICROPARTICLES TO COMBAT ANTIMICROBIAL RESISTANCE
Dr Anjana Jayasree,
Postdoctoral Research Fellow
School of Pharmacy and Pharmaceutical Sciences
The University of Queensland, Australia
RESEARCHER PROFILE
Filmed in Brisbane, Australia | December 2025
Dr Anjana Jayasree is an emerging research leader in biomaterials, tissue engineering and nanotechnology, recognised internationally for her innovative work on antimicrobial nanoparticles and regenerative therapies. A Postdoctoral Research Fellow at The University of Queensland, she operates at the intersection of materials science, drug delivery and cellular biology, developing advanced metallic-based nanotechnologies to improve both human and animal health outcomes. Her expertise spans nanoparticle synthesis, cell–material interactions, and the design of sophisticated in vitro models to investigate soft-tissue integration, osseointegration, angiogenesis and biofilm formation.
A central pillar of Dr Jayasree’s research is the engineering of next-generation metallic implants with precisely tailored surface modifications that enhance cellular attachment while simultaneously minimising bacterial colonisation and biofilm formation. By integrating bioactive ions, nanoscale architectures and smart antibacterial coatings, her work aims to accelerate healing, strengthen soft-tissue integration and significantly reduce implant-associated infection rates. This multidisciplinary program positions her at the forefront of innovation in regenerative dentistry and biomaterials-driven solutions to antimicrobial resistance.
Beyond her research, Dr Jayasree is a passionate advocate for STEM education and public engagement. She contributes to national outreach programs including Soapbox Science, the Kids STEM Convention and the Wonder of Science Young Science Ambassador initiative, inspiring the next generation of scientists through hands-on learning and accessible communication.
Driven, collaborative and highly creative, Dr Jayasree continues to advance impactful research that bridges fundamental science with real-world clinical and industry needs.
Source: Supplied
https://orcid.org/0000-0003-4719-0174
-
Exercise program for the prevention of osteoporotic fracture
Dr Beck is an international leader in the effects of mechanical loading on bone health. Dr Beck graduated from The University of Queensland (BHMS[Ed]) and the University of Oregon (MSc and PhD) and completed a postdoctoral research fellowship in the Stanford University School of Medicine (California, USA.) She is a Professor of Exercise Science at Griffith University Gold Coast campus, where she has led the Bone Densitometry Research Laboratory since 2004.
-
Stem cell therapies for enteric neuropathies
Dr Stamp is a Group Leader in the Department of Anatomy and Physiology at the University of Melbourne, Australia. Dr Stamp’s PhD research (with Prof Martin Pera, Monash University) focused on the derivation of hepatopancreatic progenitors from human embryonic stem cells. He then joined the lab of Dr Don Newgreen at the Murdoch Childrens Research Institute where he began working on development of the enteric nervous system (ENS), before joining Prof Heather Young’s lab at the University of Melbourne, where he focused on developing a stem cell therapy to treat gut motility disorders such as the paediatric enteric neuropathy Hirschprung disease.
-
Prescribing exercise to regional population with cardiovascular disease & diabetes
Associate Professor Gordon’s research is aimed at determining the optimal methods of prescribing and implementing exercise as part of the health care plan for people with cardiovascular disease and diabetes. Specifically, he is leading work to determine if and how the components of exercise can be considered as a whole for prescribing exercise to generate health benefits. This is important to overcome the series of barriers that people living in rural and regional areas experience when trying to become active.
